Balance Sheet

Accounts Payables Accumulated Expenses Assets Capital Leases Cash & Current Investments Cash & Equivalents Common Equity Construction in Progress Convertible Debt Current Assets Current Deferred Revenue Current Leases Current Taxes Finished Goods Goodwill & Intangibles Intangibles Inventory Liabilities and Shareholders Equity Liabilities from Discontinued Operations Long-Term Deferred Tax Long-Term Investments Non-Current Assets Non-Current Debt Non-Current Deferred Tax Liability Non-Current Deffered Revenue Notes Payables Operating Leases Other Accumulated Expenses Other Non-Current Assets Other Non-Current Liabilities Payables Pension Prepaid Assets Property, Plant & Equipment (Net)Raw Materials Receivables Receivables - Net Retained Earnings Shareholder's Equity Short term Debt Short-term Investments Total Current Liabilities Total Debt Total Liabilities Total Non-Current Liabilities Treasury Shares Work In Process

Daily Values

Growth Metrics

Others

Trinity Biotech (TRIB) Receivables - Other (2023 - 2024)

Historic Receivables - Other for Trinity Biotech (TRIB) over the last 2 years, with Q4 2024 value amounting to $168000.0.

Trinity Biotech's Receivables - Other rose 5700.93% to $168000.0 in Q4 2024 from the same period last year, while for Dec 2024 it was $168000.0, marking a year-over-year increase of 5700.93%. This contributed to the annual value of $168000.0 for FY2024, which is 5700.93% up from last year.
According to the latest figures from Q4 2024, Trinity Biotech's Receivables - Other is $168000.0, which was up 5700.93% from $107000.0 recorded in Q4 2023.
In the past 5 years, Trinity Biotech's Receivables - Other ranged from a high of $168000.0 in Q4 2024 and a low of $107000.0 during Q4 2023